Thunborg, Charlotta
Wang, Rui
Rosenberg, Anna
Sindi, Shireen
Andersen, Pia
Andrieu, Sandrine
Broersen, Laus M.
Coley, Nicola
Couderc, Celine
Duval, Celine Z.
Faxen-Irving, Gerd
Hagman, Göran
Hallikainen, Merja
Håkansson, Krister
Kekkonen, Eija
Lehtisalo, Jenni
Levak, Nicholas
Mangialasche, Francesca
Pantel, Johannes
Rydström, Anders
Stigsdotter-Neely, Anna
Wimo, Anders
Ngandu, Tiia
Soininen, Hilkka
Hartmann, Tobias
Solomon, Alina
Kivipelto, Miia
Funding for this research was provided by:
Joint Program of Neurodegenerative Disorders – JPND
Alzheimerfonden
Center for Innovative Medicine
Hjärnfonden
Region Stockholm
Stockholms Sjukhem and the Jubilee Program
Stockholms Sjukhem
Swedish Research Council for Health Working Life and Welfare
European Research Council grant (804371)
NordForsk NJ-FINGERS grant
Swedish Research Council
Karolinska Institute
Article History
Received: 18 February 2024
Accepted: 27 April 2024
First Online: 30 May 2024
Declarations
:
: MIND-AD<sub>mini</sub> was approved by the relevant local ethical committees in all four countries. Participants and study partners gave their written informed consent before enrolment in the trial.
: Not applicable.
: Prof. Miia Kivipelto is the Editors-in-Chief of Alzheimer's Research & Therapy. Dr. Anna Rosenberg serves as Associate Editor for Alzheimer's Research & Therapy.